| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.23▼ | 3.26▼ | 3.24▼ | 3.29▼ | 3.24▼ |
| MA10 | 3.26▼ | 3.32▼ | 3.33▼ | 3.44▼ | 3.84▼ |
| MA20 | 3.34▼ | 3.33▼ | 3.35▼ | 3.27▼ | 5.79▼ |
| MA50 | 3.40▼ | 3.39▼ | 3.35▼ | 4.02▼ | 19.92▼ |
| MA100 | 3.35▼ | 3.34▼ | 3.44▼ | 5.94▼ | 28.09▼ |
| MA200 | 3.59▼ | 4.61▼ | 5.06▼ | 12.82▼ | 35.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | -0.016▼ | -0.020▼ | 0.066▲ | 0.618▲ |
| RSI | 39.243▼ | 41.729▼ | 42.677▼ | 40.656▼ | 26.174▼ |
| STOCH | 23.698 | 17.652▼ | 24.098 | 42.992 | 8.527▼ |
| WILL %R | -92.593▼ | -94.030▼ | -94.030▼ | -65.116 | -91.728▼ |
| CCI | -75.045 | -96.893 | -110.498▼ | -35.977 | -69.786 |
|
Thursday, November 19, 2026 04:44 AM
Clinical-stage biotechnology company Immutep Limited (NASDAQ:IMMP) announced Phase 2 data showing an 81.1% 12-month disease-free survival rate for its combination regimen in high-risk, resectable soft ...
|
|
Wednesday, November 18, 2026 11:44 PM
Immutep Limited (NASDAQ: IMMP) presented new survival data from its EFTISARC-NEO Phase II trial at the Connective Tissue Oncology Society 2026 Annual Meeting, showing a 12-month disease-free survival ...
|
|
Wednesday, November 18, 2026 04:01 PM
Poster presented today at CTOS 2026 expands on the survival data first reported in the abstract (announced 11 November 2026), which showed a 12-month disease-free survival (DFS) of 81.1% in patients ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/11/26 | 3.41 | 3.41 | 3.0933 | 3.11 | 44,784 |
| 19/11/26 | 3.31 | 3.57 | 3.31 | 3.42 | 82,876 |
| 18/11/26 | 3.16 | 3.4999 | 3.06 | 3.25 | 138,152 |
| 17/11/26 | 3.39 | 3.39 | 3.163 | 3.26 | 6,833 |
| 16/11/26 | 3.41 | 3.50 | 3.20 | 3.40 | 26,679 |
| 13/11/26 | 3.65 | 3.76 | 3.4221 | 3.48 | 14,849 |
| 12/11/26 | 3.30 | 3.95 | 3.30 | 3.655 | 61,541 |
| 11/11/26 | 3.69 | 3.74 | 3.43 | 3.56 | 58,707 |
| 10/11/26 | 3.63 | 3.69 | 3.40 | 3.46 | 81,308 |
| 09/11/26 | 3.62 | 3.92 | 3.6068 | 3.80 | 65,950 |
|
|
||||
|
|
||||
|
|